The Clinical Effects of Rosiglitazone and Metformin in the Treatment of 36 the Polycystic Ovary Syndrome (PCOS) Patients with Hyperinsulinemia

PAN Hong-yan,LV Zheng,LI Qiang
DOI: https://doi.org/10.3760/cma.j.issn.1673-8799.2009.06.12
2009-01-01
Abstract:Objective To investigate the clinical effects of Rosiglitazone and Mefformin in the treat-ment of the polycystic ovary syndrome (PCOS) patients with hyperinsulinemia. Methods Thirty-six PCOS women with hyperinsulinemia participated in the study and were administered with Mefformin at a dose of 500 mg three times a day and Rosiglitazone 4 mg one time a day. Serum insulin, glucose, HOMA-IR, sex hormones and BMI were evaluated before and then after a 12 week and 24 week therapy. Results After treatment,fasting insulin, testosterone, LH and BMI level decreased (P<0.05). Conclusion Rosiglitazone and Metformin is an effective management in therapy of PCOS patients with hyperinsulinemia.
What problem does this paper attempt to address?